The role of the NMDA synapse in general anesthesia.

A theory of anesthesia is presented. It consists of four hypotheses. (1) The occurrence of states of consciousness causally depends on the formation of transient higher-order, self-referential mental representations. The occurrence of such states is identical with the appearance of conscious phenomena. Loss of consciousness will occur, if the brain's representational activity falls below a critical threshold. (2) Higher-order mental representations are instantiated by neural cell assemblies. (3) The formation of such assemblies involves the activation of the NMDA receptor channel complex. The activation state of this receptor determines the rate at which such assemblies are generated. (4) Modification of NMDA-dependent computational processes is the final common pathway of anesthetic action. Agents that directly inactivate the NMDA synapse necessarily have anesthetic properties; agents that do not directly affect the NMDA synapse will exert an anesthetic action, if they inhibit NMDA-dependent processes.

[1]  L C Daniell.  Alteration of general anesthetic potency by agonists and antagonists of the polyamine binding site of the N-methyl-D-aspartate receptor. , 1992, The Journal of pharmacology and experimental therapeutics.

[2]  D. Armstrong,et al.  The Nature of Mind and Other Essays , 1983 .

[3]  D. Lodge,et al.  Phencyclidine receptors and N-methyl-D-aspartate antagonsim: Electrophysiologic data correlates with known behaviours , 1988, Pharmacology Biochemistry and Behavior.

[4]  P. Churchland.  Reduction, Qualia, and the Direct Introspection of Brain States , 1985 .

[5]  Qualia and Brain Processes , 1992 .

[6]  H. Flohr,et al.  An information processing theory of anaesthesia , 1995, Neuropsychologia.

[7]  Hans Flohr,et al.  Brain Processes and Phenomenal Consciousness , 1991 .

[8]  J. Woods,et al.  Analgesic, anesthetic, and respiratory effects of the competitiveN-methyl-d-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys , 1990, Brain Research.

[9]  Paul L Huang,et al.  Effects of Targeted Neuronal Nitric Oxide Synthase Gene Disruption and Nitro sup G -L-Arginine Methylester on the Threshold for Isoflurane Anesthesia , 1995, Anesthesiology.

[10]  Takao Shimizu,et al.  Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice , 1992, Brain Research.

[11]  L. C. Daniell,et al.  The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics , 1990, Pharmacology Biochemistry and Behavior.

[12]  David Rosenthal,et al.  Higher‐order thoughts and the appendage theory of consciousness , 1993 .

[13]  W. Löscher,et al.  Comparison of pharmacodynamic effects of the non-competitive NMDA receptor antagonists MK-801 and ketamine in pigs. , 1991, European journal of pharmacology.

[14]  C. Boast,et al.  Characterization of motor activity patterns induced by N-methyl-D-aspartate antagonists in gerbils , 1987, Pharmacology Biochemistry and Behavior.

[15]  L. C. Daniell.  Effect of CGS 19755, a competitive N-methyl-D-aspartate antagonist, on general anesthetic potency , 1991, Pharmacology Biochemistry and Behavior.

[16]  E F Domino,et al.  Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581 , 1966, Anesthesia and analgesia.

[17]  D. Middlemiss,et al.  In vivo labelling of the NMDA receptor channel complex by [3H]MK-801. , 1988, European journal of pharmacology.

[18]  F. Colpaert,et al.  The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. , 1989, The Journal of pharmacology and experimental therapeutics.

[19]  H. Flohr.  Sensations and brain processes , 1995, Behavioural Brain Research.

[20]  W. J. Perkins,et al.  CORRELATION BETWEEN ANESTHETIC POTENCY AND RECEPTOR BINDING CONSTANT FOR NONCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS , 1992 .

[21]  R. Bullock,et al.  Neuroprotective Doses of N‐Methyl‐D‐Aspartate Receptor Antagonists Profoundly Reduce the Minimum Alveolar Anesthetic Concentration (MAC) for Isoflurane in Rats , 1993, Anesthesia and analgesia.

[22]  J. Liebman,et al.  Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist. , 1988, The Journal of pharmacology and experimental therapeutics.

[23]  David Rosenthal,et al.  Thinking that one thinks. , 1993 .

[24]  P. Charlesworth,et al.  Pentobarbitone modulation of NMDA receptors in neurones isolated from the rat olfactory brain , 1995, British journal of pharmacology.

[25]  M. Zornow,et al.  The noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits , 1989, Neuropharmacology.

[26]  F Dexter,et al.  Glycine Receptor Antagonism: Effects of ACEA-1021 on the Minimum Alveolar Concentration for Halothane in the Rat , 1995, Anesthesiology.

[27]  W. Koek,et al.  Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. , 1986, Life sciences.

[28]  T. Cicero,et al.  Effects of nitric oxide-related agents on alcohol narcosis. , 1994, Alcoholism, clinical and experimental research.

[29]  D. Rosenthal.  Two concepts of consciousness , 1986 .

[30]  Thomas Metzinger.  Subjekt und Selbstmodell , 1993 .

[31]  R. Johns,et al.  Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness? , 1992, Anesthesiology.

[32]  R. Johns,et al.  Nitrict Oxide Synthase Inhibitors, 7-Nitro Indazole and Nitro sup G -L-Arginine Methyl Ester, Dose Dependently Reduce the Threshold for Isoflurane Anesthesia , 1996, Anesthesiology.